Skip to main content
SpringerLink
Log in

Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases

  • Original Papers
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Tetrahydroisoquinoline (TIQ) alkaloids and 1-carboxy TIQ derivatives have been found in human fluids and/or tissues. The possible biosynthetic pathways of salsolinol (Sal), taken as an example of TIQs, are discussed, and the possibility that biosynthesis occurs through a stereospecific enzymatic reaction is considered. In this respect, it is reported that the R enantiomer of Sal predominates in urines of healthy volunteers, whereas the S enantiomer predominates in port wine and possibly in other beverages and foods, suggesting that Sal present in humans could have, at least partially, and endogenous enzymatic origin.

TIQs and other dopamine-derived alkaloids are weak MAO inhibitors, the R enantiomer of Sal and salsolidine being more potent than the S form.

The changes in monoamine oxidase activity and the nigrostriatal concentrations of dopamine and homovanillic acid in Parkinson's and Huntington's diseases and in alcoholism are reviewed. In these pathological situations, changes in the levels of dopamine-derived alkaloid levels may occur. The possibility that the modifications found might cause or contribute to changes in mental and/or neurophysiological states in these pathological situations is considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adachi J, Mizoi Y, Fukanaga T (1986) Effect of acetaldehyde on urinary salsolinol in healthy man after ethanol intake. Alcohol 3: 215–220

    Google Scholar 

  • Bail M, Miller S, Cohen G (1980) Selective 7-O-methylation of salsolinol in rat brain and heart in vivo. Life Sci 26: 2051–2060

    Google Scholar 

  • Bernheimer H, Hornykiewicz O (1973) Brain amines in Huntington's chorea. In: Barbeau A, Chase TN, Paulson GW (eds) Advances in neurology, vol 1. Raven Press, New York, pp 525–531

    Google Scholar 

  • Bird ED, Iversen LL (1974) Huntington's chorea-post mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain 97: 457–472

    Google Scholar 

  • Brown ZW, Amit Z, Smith B (1980) Examination of the role of tetrahydroisoquinoline alkaloids in the mediation of ethanol consumption in rats. Adv Exp Med Biol 126: 103–120

    Google Scholar 

  • Camp VM, Lenton JD, Stammers JW, Lee SR, Faraj BA (1986) The development of a radioenzymatic assay for urinary salsolinol. J Nucl Med 27: 893

    Google Scholar 

  • Cardinale GJ, Donnerer J, Finck AD, Kantrowitz JD, Oka K, Spector S (1987) Morphine and codeine are endogenous components of human cerebrospinal fluid. Life Sci 40: 301–306

    Google Scholar 

  • Carlsson A, Adolfsson R, Aquilonius S-M, Gottfries C-G, Oreland L, Svennerholm L, Winblad B (1980) Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. In: Goldstein M, Calne BD, Lieberman A (eds) Ergot compounds and brain function. Neuroendocrine and neuropsychiatric aspects. Raven Press, New York, pp 295–304

    Google Scholar 

  • Cashkw JL, McMurtrey KD, Brown H, Davis VE (1974) Identification of catecholamine-derived alkaloids in mammals by gas chromatography and mass spectrometry. J Chromatogr 99: 567–573

    Google Scholar 

  • Cashkw JL, Ruchirkwat S, Nimit Y, Davis VE (1983) Regioselective O-methylation of tetrahydropapaveroline and tetrahydroxyberberine in vivo in rat brain. Biochem Pharmacol 32: 3163–3169

    Google Scholar 

  • Clow A, Stolerman IP, Murray RM, Sandler M (1983) Ethanol preference in rats: increased consumption after intraventricular administration of tetrahydropapaveroline. Neuropharmacology 22: 563–565

    Google Scholar 

  • Clow A, Topham A, Saunders JB, Murray R, Sandler M (1985) The role of salsolinol in alcohol intake, and withdrawal. Prog Clin Biol Res 183: 101–113

    Google Scholar 

  • Collins MA, Bigdeli MG (1975) Tetrahydroisoquinolines in vivo I. Rat brain formation of salsolinol, a condensation product of dopamine and acetaldehyde, under certain conditions during ethanol intoxication. Life Sci 16: 585–602

    Google Scholar 

  • Collins MA, Nijm WP, Borge GF, Teas G, Golfarb C (1979) Dopamine-related tetrahydroisoquinolines: significant urinary excretion by alcoholics after alcohol consumption. Science 206: 1184–1186

    Google Scholar 

  • Collins MA, Dahl K, Nijm WP, Major LF (1982) Evidence for homologous families of dopamine (DA) and serotonin (5-HT) condensation products in cerebrospinal fluids (CSF) from monkeys. Soc Neurosci 8: 277

    Google Scholar 

  • Coscia CJ, Burke W, Jamroz G, Lasala JM, McFarlane J, Mitchell J, O'Toole MM, Wilson ML (1977) Occurrence of a new class of tetrahydroisoquinoline alkaloids in L-dopatreated parkinsonian patients. Nature 269: 617–619

    Google Scholar 

  • Davis VE, Walsh MJ, Yamanaka Y (1970) Augmentation of alkaloid formation from dopamine by alcohol and acetaldehyde in vitro. J Pharmacol Exp Ther 174: 401–412

    Google Scholar 

  • Deitrich R, Erwin V (1980) Biogenic amine-aldehyde condensation products: tetrahydroisoquinolines and tryptolines (β-carbolines). Ann Rev Pharmacol Toxicol 20: 55–80

    Google Scholar 

  • Deitrich RA, Erwin VG (1984) Interaction of amine metabolism and alcohol actions. In: Tipton KF, Dostert P, Strolin Benedetti M (eds) Monoamine oxidase and disease. Prospects for therapy with reversible inhibitors. Academic Press, London, pp 275–289

    Google Scholar 

  • Dordain G, Goujet M-A, Simon P (1974) Essai clinique préliminaire de la tétrahydropapavéroline dans la maladie de Parkinson. Thérapie 29: 429–434

    Google Scholar 

  • Dordain G, Dostert P, Strolin Benedetti M, Rovei V (1984) Tetrahydroisoquinoline derivatives and Parkinsonism. In: Tipton KF, Dostert P, Strolin Benedetti M (eds) Monoamine oxidase and disease. Prospects for therapy with reversible inhibitors. Academic Press, London, pp 417–426

    Google Scholar 

  • Dostert P, Strolin Benedetti M, Dedieu M (1987) Ratio of enantiomers of salsolinol in human urine. Pharmacol Toxicol 60 [Suppl] 1: 13

    Google Scholar 

  • Dougan D, Wade D, Mearrick P (1975) Effects of L-dopa metabolites at a dopamine receptor suggest a basis for “on-off” effect in Parkinson's disease. Nature 254: 70–71

    Google Scholar 

  • Fornazzari L, Carlen PL (1982) Transient chloreiform dyskinesias during alcohol withdrkwal. Can J Neurol Sci 9: 89–90

    Google Scholar 

  • Giovine A, Renis M, Bertolino A (1976) In vivo and in vitro studies on the effect of tetrahydropapaveroline and salsolinol on COMT and MAO activity in rat brain. Pharmacology 14: 86–94

    Google Scholar 

  • Gynther J, Lapinjoki SP, Airaksinen MM, Peura P (1986) Decarboxylation of 1,2,3,4-tetrahydro-β-carboline-1-carboxylic acids in brain homogenate and catalysis by pyridoxal-5′-phosphate. Biochem Pharmacol 35: 2671–2675

    Google Scholar 

  • Hornykiewicz O, Kish SJ (1986) Biochemical pathophysiology of Parkinson's Disease. Adv Neurol 45: 19–34

    Google Scholar 

  • Jellinger K, Riederer P (1984) Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intracerebral MAO activity. Adv Neurol 40: 199–210

    Google Scholar 

  • Kanazawa I, Tanaka Y, Cho F (1986) “Choreic” movement induced by unilateral kainate lesion of the striatum and L-dopa administration in monkey. Neurosci Lett 71: 241–246

    Google Scholar 

  • Kapadia GJ, Subba Rao G, Leete E, Fayez MBE, Vaishnav YN, Fales HM (1970) On the origin of carbon 1 in tetrahydroisoquinoline alkaloids. J Am Chem Soc 92: 6943–6951

    Google Scholar 

  • Lal S, de la Vega CE (1975) Apomorphine and psychopathology. J Neurol Neurosurg Psychiatry 38: 722–726

    Google Scholar 

  • Littleton J (1978) Alcohol and neurotransmitters. Clin Endocrin Metab 7: 369–384

    Google Scholar 

  • Mann JJ, Kaplan RD, Bird ED (1986) Elevated postmortem monoamine oxidase B activity in the caudate nucleus in Huntington's disease compared to schizophrenics and controls. J Neural Transm 65: 277–283

    Google Scholar 

  • Melamed E, Hefti F, Bird ED (1982) Huntington's chorea is not associated with hyperactivity of nigrostriatal dopaminergic neurons: studies in post mortem tissues and in rats with kainic acid lesions. Neurology 32: 640–644

    Google Scholar 

  • Melchior CL, Mueller A, Deitrich RA (1980) Half-lives of salsolinol and tetrahydropapaveroline hydrobromide following intracerebroventricular injection. Biochem Pharmacol 29: 657–658

    Google Scholar 

  • Meyerson LR, McMurtrey KD, Davis VE (1976) Neuroamine-derived alkaloids: substrate-preferred inhibitors of rat brain monoamine oxidase in vitro. Biochem Pharmacol 25: 1013–1020

    Google Scholar 

  • Myers RD, Melchior CL (1977a) Alcohol drinking: abnormal intake caused by tetrahydropapaveroline in brain. Science 196: 554–556

    Google Scholar 

  • Myers RD, Melchior CL (1977b) Differential actions on voluntary alcohol intake of tetrahydroisoquinolines or a β-carboline infused chronically in the ventricle of the rat. Pharmacol Biochem Behav 7: 381–392

    Google Scholar 

  • Myers WD, Ng KT, Singer G, Smythe GA, Duncan MW (1985) Dopamine and salsolinol levels in rat hypothalami and striatum after schedule-induced self-injection (SISI) of ethanol and acetaldehyde. Brain Res 358: 122–128

    Google Scholar 

  • O'Carroll A-M, Fowler CJ, Phillips JP, Tobbia I, Tipton KF (1983) The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions. Naunyn Schmiedebergs Arch Pharmacol 322: 198–202

    Google Scholar 

  • Oreland L, Wiberg Å, Winblad B, Fowler CJ, Gottfries C-G, Kiianmaa K (1983) The activity of monoamine oxidase -A and -B in brains from chronic alcoholics. J Neural Transm 56: 73–83

    Google Scholar 

  • Origitano T, Hannigan J, Collins MA (1981) Rat brain salsolinol and blood-brain barrier. Brain Res 224: 446–451

    Google Scholar 

  • Reynolds GP, Garrett NJ (1986) Striatal dopamine and homovanillic acid in Huntington's disease. J Neural Transm 65: 151–155

    Google Scholar 

  • Rueffer M, El-Shagi H, Nagakura N, Zenk MH (1981) (S)-Norlaudanosoline synthase: the first enzyme in the benzylisoquinoline biosynthetic pathway. FEBS Lett 129: 5–9

    Google Scholar 

  • Sandler M, Bonham Carter S, Hunter KR, Stern GM (1973) Tetrahydroisoquinoline alkaloids: in vivo metabolites of L-dopa in man. Nature 241: 439–443

    Google Scholar 

  • Sandler M, Glover V, Armando I, Clow A (1982) Pictet-Spengler condensation products, stress and alcoholism: some clinical overtones. Prog Clin Biol Res 90: 215–226

    Google Scholar 

  • Siggins GR, Berger T, French ED, Shier T, Bloom FE (1982) Ethanol, salsolinol and tetrahydropapaveroline alter the discharge of neurons in several brain regions: comparison to opioid effects. Prog Clin Biol Res 90: 275–287

    Google Scholar 

  • Sjöquist B, Magnuson E (1980) Analysis of salsolinol and salsoline in biological samples using deuterium-labelled internal standards and gas chromatography-mass spectrometry. J Chromatogr 183: 17–24

    Google Scholar 

  • Sjöquist B, Borg S, Kvande H (1981a) Catecholamine derived compounds in urine and cerebrospinal fluid from alcoholics during and after long-standing intoxication. Subst Alcohol Actions Misuse 2: 63–72

    Google Scholar 

  • Sjöquist B, Borg S, Kvande H (1981b) Salsolinol and methylated salsolinol in urine and cerebrospinal fluid from healthy volunteers. Subst Alcohol Actions Misuse 2: 73–77

    Google Scholar 

  • Sjöquist B, Eriksson A, Winblad B (1982) Salsolinol and catecholamines in human brain and their relation to alcoholism. Prog Clin Biol Res 90: 57–67

    Google Scholar 

  • Sjöquist B (1985) 1-Carboxysalsolinol, a minor dopamine metabolite, in human urine, cerebrospinal fluid and brain tissue. J Neurochem 44 [Suppl S]: 191

    Google Scholar 

  • Smythe GA, Duncan MW (1985) Precise GC/MS assays for salsolinol and tetrahydropapaveroline: the question of artifacts and dietary sources and the influence of alcohol. Prog Clin Biol Res 183: 77–84

    Google Scholar 

  • Sourkes TL (1971) Possible new metabolites mediating actions of L-Dopa. Nature 229: 413–414

    Google Scholar 

  • Spokes EGS (1980) Neurochemical alterations in Huntington's chorea. Brain 103: 179–210

    Google Scholar 

  • Streifler M, Rabey MJ (1983) Long-term effects of L-Deprenyl in chronic levodopa treated parkinsonian patients. J Neural Transm [Suppl] 19: 265–272

    Google Scholar 

  • Strolin Benedetti M, Dostert P, Dedieu M (1986) Ratio of enantiomers of salsolinol in human urine and effect of food. In: 15th C.I.N.P. Congress, Puerto Rico, December 14–17, book of abstracts, P-56

  • Tipton KF, Houslay MD, Turner AJ (1977) Metabolism of aldehydes in brain. Essays Neurochem Neuropharmacol 1: 103–138

    Google Scholar 

  • Turner AJ, Baker KM, Algeri S, Frigerio A, Garattini S (1974) Tetrahydropapaveroline: formation in vivo and in vitro in rat brain. Life Sci 14: 2247–2257

    Google Scholar 

Download references

Author information

Author notes

  1. P. Dostert

    Present address: Farmitalia Carlo Erba, Milan, Italy

Authors and Affiliations

  1. Farmitalia Carlo Erba, Milan, Italy

    M. Strolin Benedetti

  2. CHU Clermont Ferrand, Clermont Ferrand, France

    G. Dordain

Authors
  1. P. Dostert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Strolin Benedetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Dordain
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dostert, P., Strolin Benedetti, M. & Dordain, G. Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases. J. Neural Transmission 74, 61–74 (1988). https://doi.org/10.1007/BF01245140

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01245140

Keywords

Search

Navigation